Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
April-2019 Volume 17 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April-2019 Volume 17 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Pretreatment with neuregulin‑1 improves cardiac electrophysiological properties in a rat model of myocardial infarction

  • Authors:
    • Panpan Rao
    • Ziqiang Liu
    • Huinan Duan
    • Song Dang
    • Haitao Li
    • Liang Zhong
    • Xin Wang
    • Long Wang
    • Xi Wang
  • View Affiliations / Copyright

    Affiliations: Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China, Department of Cardiology, Hainan General Hospital, Haikou, Hainan 570100, P.R. China, Department of Anesthesiology, Wuhan Medical and Healthcare Center for Women and Children, Wuhan, Hubei 430015, P.R. China
    Copyright: © Rao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 3141-3149
    |
    Published online on: February 25, 2019
       https://doi.org/10.3892/etm.2019.7306
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Neuregulin‑1 (NRG‑1) is considered to be a potential therapeutic agent for cardiovascular diseases due to its diverse protective effects. The aim of the present study was to investigate the effect of NRG‑1 on cardiac electrophysiology in rats with myocardial infarction (MI). The rats were randomly divided into three groups: The sham operation group (SO; n=8); MI group (n=8); and the MI with recombinant human NRG (rhNRG)‑1 administration group (NRG‑1 group; 10 µg/kg; n=8). A rat MI model was established via ligation of the left anterior descending coronary artery. The rats in the NRG‑1 group received a 10 µg/kg rhNRG‑1 injection through the tail vein 30 min prior to ligation. Following 24 h of intervention, the field potential (FP) parameters, including the interspike interval (ISI), field potential duration (FPD), FPrise, FPmin, FPmax and conduction velocity (CV), were measured using microelectrode array technology. Subsequently, burst pacing was performed to assess ventricular arrhythmia (VA) susceptibility in the left ventricle. FP parameters in the MI group were significantly different when compared with those observed in the SO group. ISI, FPD, FPrise and FPmax in the infarct, peri‑infarct and normal zones, as well as the CV of the infarct and peri‑infarct zones, were all significantly decreased, and FPmin in the normal zone was increased (P<0.05). However, when compared with the MI group, NRG‑1 prolonged the ISI and FPD in the 3 zones, and increased FPrise in the infarct zone, FPmax in the normal zone and CV in the peri‑infarct zone; it also decreased FPmin in the normal zone (P<0.05). Furthermore, the incidence of VA was significantly reduced in the NRG‑1 group when compared with the MI group (P<0.05). In conclusion, NRG‑1 improved cardiac electrophysiological properties and reduced VA susceptibility in acute MI.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Falls DL: Neuregulins: Functions, forms, and signaling strategies. Exp Cell Res. 284:14–30. 2003. View Article : Google Scholar : PubMed/NCBI

2 

Marchionni MA, Goodearl AD, Chen MS, Bermingham- McDonogh O, Kirk C, Hendricks M, Danehy F, Misumi D, Sudhalter J and Kobayashi K: Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system. Nature. 362:312–318. 1993. View Article : Google Scholar : PubMed/NCBI

3 

Yarden Y and Sliwkowski MX: Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2:127–137. 2001. View Article : Google Scholar : PubMed/NCBI

4 

Brinkmann BG, Agarwal A, Sereda MW, Garratt AN, Müller T, Wende H, Stassart RM, Nawaz S, Humml C, Velanac V, et al: Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system. Neuron. 59:581–595. 2008. View Article : Google Scholar : PubMed/NCBI

5 

Matsukawa R, Hirooka Y, Ito K, Honda N and Sunagawa K: Central neuregulin-1/ErbB signaling modulates cardiac function via sympathetic activity in pressure overload-induced heart failure. J Hypertens. 32:817–825. 2014. View Article : Google Scholar : PubMed/NCBI

6 

Matsukawa R, Hirooka Y, Nishihara M, Ito K and Sunagawa K: Neuregulin-1/ErbB signaling in rostral ventrolateral medulla is involved in blood pressure regulation as an antihypertensive system. J Hypertens. 29:1735–1742. 2011. View Article : Google Scholar : PubMed/NCBI

7 

Montaigne D, Hurt C and Neviere R: Mitochondria death/survival signaling pathways in cardiotoxicity induced by anthracyclines and anticancer-targeted therapies. Biochem Res Int. 2012:9515392012. View Article : Google Scholar : PubMed/NCBI

8 

Rupert CE and Coulombe KL: The roles of neuregulin-1 in cardiac development, homeostasis, and disease. Biomark Insights. 10 (Suppl 1):S1–S9. 2015.

9 

Hill MF, Patel AV, Murphy A, Smith HM, Galindo GL, Pentassuglia L, Peng X, Lenneman CG, Odiete O, Friedman DB, et al: Intravenous glial growth factor 2 (GGF2) isoform of neuregulin-1β improves left ventricular function, gene and protein expression in rats after myocardial infarction. PLoS One. 8:e557412013. View Article : Google Scholar : PubMed/NCBI

10 

Bersell K, Arab S, Haring B and Kühn B: Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell. 138:257–270. 2009. View Article : Google Scholar : PubMed/NCBI

11 

Gao R, Zhang J, Cheng L, Wu X, Dong W, Yang X, Li T, Liu X, Xu Y, Li X and Zhou M: A Phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure. J Am Coll Cardiol. 55:1907–1914. 2010. View Article : Google Scholar : PubMed/NCBI

12 

Jabbour A, Hayward CS, Keogh AM, Kotlyar E, McCrohon JA, England JF, Amor R, Liu X, Li XY, Zhou MD, et al: Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses. Eur J Heart Fail. 13:83–92. 2011. View Article : Google Scholar : PubMed/NCBI

13 

Xiao J, Li B, Zheng Z, Wang M, Peng J, Li Y and Li Z: Therapeutic effects of neuregulin-1 gene transduction in rats with myocardial infarction. Coron Artery Dis. 23:460–468. 2012. View Article : Google Scholar : PubMed/NCBI

14 

Formiga FR, Pelacho B, Garbayo E, Imbuluzqueta I, Díaz-Herráez P, Abizanda G, Gavira JJ, Simón-Yarza T, Albiasu E, Tamayo E, et al: Controlled delivery of fibroblast growth factor-1 and neuregulin-1 from biodegradable microparticles promotes cardiac repair in a rat myocardial infarction model through activation of endogenous regeneration. J Control Release. 173:132–139. 2014. View Article : Google Scholar : PubMed/NCBI

15 

Gu X, Liu X, Xu D, Li X, Yan M, Qi Y, Yan W, Wang W, Pan J, Xu Y, et al: Cardiac functional improvement in rats with myocardial infarction by up-regulating cardiac myosin light chain kinase with neuregulin. Cardiovasc Res. 88:334–343. 2010. View Article : Google Scholar : PubMed/NCBI

16 

Galindo CL, Kasasbeh E, Murphy A, Ryzhov S, Lenihan S, Ahmad FA, Williams P, Nunnally A, Adcock J, Song Y, et al: Anti-remodeling and anti-fibrotic effects of the neuregulin-1β glial growth factor 2 in a large animal model of heart failure. J Am Heart Assoc. 3:e0007732014. View Article : Google Scholar : PubMed/NCBI

17 

Mendes-Ferreira P, De Keulenaer GW, Leite-Moreira AF and Brás-Silva C: Therapeutic potential of neuregulin-1 in cardiovascular disease. Drug Discov Today. 18:836–842. 2013. View Article : Google Scholar : PubMed/NCBI

18 

Parodi EM and Kuhn B: Signalling between microvascular endothelium and cardiomyocytes through neuregulin. Cardiovasc Res. 102:194–204. 2014. View Article : Google Scholar : PubMed/NCBI

19 

Huertas-Vazquez A, Teodorescu C, Reinier K, Uy-Evanado A, Chugh H, Jerger K, Ayala J, Gunson K, Jui J, Newton-Cheh C, et al: A common missense variant in the neuregulin 1 gene is associated with both schizophrenia and sudden cardiac death. Heart Rhythm. 10:994–998. 2013. View Article : Google Scholar : PubMed/NCBI

20 

Napolitano C: Heart, brain, and the risk of sudden death. Heart Rhythm. 10:999–1000. 2013. View Article : Google Scholar : PubMed/NCBI

21 

Wang X, Liu Z, Duan HN and Wang L: Therapeutic potential of neuregulin in cardiovascular system: Can we ignore the effects of neuregulin on electrophysiology? Mini Rev Med Chem. 16:867–871. 2016. View Article : Google Scholar : PubMed/NCBI

22 

Hedhli N, Huang Q, Kalinowski A, Palmeri M, Hu X, Russell RR and Russell KS: Endothelial-derived neuregulin protects the heart against ischemic injury. Circulation. 123:2254–2262. 2011. View Article : Google Scholar : PubMed/NCBI

23 

Liang X, Ding Y, Zhang Y, Chai YH, He J, Chiu SM, Gao F, Tse HF and Lian Q: Activation of NRG1-ERBB4 signaling potentiates mesenchymal stem cell-mediated myocardial repairs following myocardial infarction. Cell Death Dis. 6:e17652015. View Article : Google Scholar : PubMed/NCBI

24 

Morano M, Angotti C, Tullio F, Gambarotta G, Penna C, Pagliaro P and Geuna S: Myocardial ischemia/reperfusion upregulates the transcription of the Neuregulin1 receptor ErbB3, but only postconditioning preserves protein translation: Role in oxidative stress. Int J Cardiol. 233:73–79. 2017. View Article : Google Scholar : PubMed/NCBI

25 

Wen HZ, Xie P, Zhang F, Ma Y, Li YL and Xu SK: Neuropilin 1 ameliorates electrical remodeling at infarct border zones in rats after myocardial infarction. Auton Neurosci. 214:19–23. 2018. View Article : Google Scholar : PubMed/NCBI

26 

Banach K, Halbach MD, Hu P, Hescheler J and Egert U: Development of electrical activity in cardiac myocyte aggregates derived from mouse embryonic stem cells. Am J Physiol Heart Circ Physiol. 284:H2114–H2123. 2003. View Article : Google Scholar : PubMed/NCBI

27 

Kienast R, Stöger M, Handler M, Hanser F and Baumgartner C: Alterations of field potentials in isotropic cardiomyocyte cell layers induced by multiple endogenous pacemakers under normal and hypothermal conditions. Am J Physiol Heart Circ Physiol. 307:H1013–H1023. 2014. View Article : Google Scholar : PubMed/NCBI

28 

Halbach M, Egert U, Hescheler J and Banach K: Estimation of action potential changes from field potential recordings in multicellular mouse cardiac myocyte cultures. Cell Physiol Biochem. 13:271–284. 2003. View Article : Google Scholar : PubMed/NCBI

29 

Hescheler J, Halbach M, Egert U, Lu ZJ, Bohlen H, Fleischmann BK and Reppel M: Determination of electrical properties of ES cell-derived cardiomyocytes using MEAs. J Electrocardiol. 37 (Suppl):110–116. 2004. View Article : Google Scholar : PubMed/NCBI

30 

Fukazawa R, Miller TA, Kuramochi Y, Frantz S, Kim YD, Marchionni MA, Kelly RA and Sawyer DB: Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt. J Mol Cell Cardiol. 35:1473–1479. 2003. View Article : Google Scholar : PubMed/NCBI

31 

Fang SJ, Wu XS, Han ZH, Zhang XX, Wang CM, Li XY, Lu LQ and Zhang JL: Neuregulin-1 preconditioning protects the heart against ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism. Chin Med J (Engl). 123:3597–3604. 2010.PubMed/NCBI

32 

Cohen JE, Purcell BP, MacArthur JW Jr, Mu A, Shudo Y, Patel JB, Brusalis CM, Trubelja A, Fairman AS, Edwards BB, et al: A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathy. Circ Heart Fail. 7:619–626. 2014. View Article : Google Scholar : PubMed/NCBI

33 

Ruhparwar A, Er F, Martin U, Radke K, Gruh I, Niehaus M, Karck M, Haverich A and Hoppe UC: Enrichment of cardiac pacemaker-like cells: Neuregulin-1 and cyclic AMP increase I(f)-current density and connexin 40 mRNA levels in fetal cardiomyocytes. Med Biol Eng Comput. 45:221–227. 2007. View Article : Google Scholar : PubMed/NCBI

34 

Brero A, Ramella R, Fitou A, Dati C, Alloatti G, Gallo MP and Levi R: Neuregulin-1beta1 rapidly modulates nitric oxide synthesis and calcium handling in rat cardiomyocytes. Cardiovasc Res. 88:443–452. 2010. View Article : Google Scholar : PubMed/NCBI

35 

Ford BD, Liu Y, Mann MA, Krauss R, Phillips K, Gan L and Fischbach GD: Neuregulin-1 suppresses muscarinic receptor expression and acetylcholine-activated muscarinic K+ channels in cardiac myocytes. Biochem Biophys Res Commun. 308:23–28. 2003. View Article : Google Scholar : PubMed/NCBI

36 

Bussek A, Wettwer E, Christ T, Lohmann H, Camelliti P and Ravens U: Tissue slices from adult mammalian hearts as a model for pharmacological drug testing. Cell Physiol Biochem. 24:527–536. 2009. View Article : Google Scholar : PubMed/NCBI

37 

Sun J, Yan H, Wugeti N, Guo Y, Zhang L, Ma M, Guo X, Jiao C, Xu W and Li T: Microelectrode array measurement of potassium ion channel remodeling on the field action potential duration in rapid atrial pacing rabbits model. Int J Clin Exp Med. 8:249–256. 2015.PubMed/NCBI

38 

Zhang Y, Guzadhur L, Jeevaratnam K, Salvage SC, Matthews GD, Lammers WJ, Lei M, Huang CL and Fraser JA: Arrhythmic substrate, slowed propagation and increased dispersion in conduction direction in the right ventricular outflow tract of murine Scn5a+/− hearts. Acta Physiol (Oxf). 211:559–573. 2014. View Article : Google Scholar : PubMed/NCBI

39 

Brito Díaz B, Alemán Sánchez JJ and Cabrera de León A: Resting heart rate and cardiovascular disease. Med Clin (Barc). 143:34–38. 2014.(In Spanish). View Article : Google Scholar : PubMed/NCBI

40 

Li Y, Li B, Zhang C, Zhang J, Zeng M and Zheng Z: Effect of NRG-1/ErbB signaling intervention on the differentiation of bone marrow stromal cells into sinus node-like cells. J Cardiovasc Pharmacol. 63:434–440. 2014. View Article : Google Scholar : PubMed/NCBI

41 

Rentschler S, Zander J, Meyers K, France D, Levine R, Porter G, Rivkees SA, Morley GE and Fishman GI: Neuregulin-1 promotes formation of the murine cardiac conduction system. Proc Natl Acad Sci USA. 99:10464–10469. 2002. View Article : Google Scholar : PubMed/NCBI

42 

Kim HG, Cho SM, Lee CK and Jeong SW: Neuregulin 1 as an endogenous regulator of nicotinic acetylcholine receptors in adult major pelvic ganglion neurons. Biochem Biophys Res Commun. 463:632–637. 2015. View Article : Google Scholar : PubMed/NCBI

43 

Di Diego JM and Antzelevitch C: Acute myocardial ischemia: Cellular mechanisms underlying ST segment elevation. J Electrocardiol. 47:486–490. 2014. View Article : Google Scholar : PubMed/NCBI

44 

Lazzara R and Scherlag BJ: Electrophysiologic basis for arrhythmias in ischemic heart disease. Am J Cardiol. 53:1B–7B. 1984. View Article : Google Scholar : PubMed/NCBI

45 

Jeevaratnam K, Guzadhur L, Goh YM, Grace AA and Huang CL: Sodium channel haploinsufficiency and structural change in ventricular arrhythmogenesis. Acta Physiol (Oxf). 216:186–202. 2016. View Article : Google Scholar : PubMed/NCBI

46 

Veerman CC, Wilde AA and Lodder EM: The cardiac sodium channel gene SCN5A and its gene product NaV1.5: Role in physiology and pathophysiology. Gene. 573:177–187. 2015. View Article : Google Scholar : PubMed/NCBI

47 

Martínez-Mármol R, David M, Sanches R, Roura-Ferrer M, Villalonga N, Sorianello E, Webb SM, Zorzano A, Gumà A, Valenzuela C and Felipe A: Voltage-dependent Na+ channel phenotype changes in myoblasts. Consequences for cardiac repair. Cardiovasc Res. 76:430–441. 2007. View Article : Google Scholar : PubMed/NCBI

48 

Corfas G and Fischbach GD: The number of Na+ channels in cultured chick muscle is increased by ARIA, an acetylcholine receptor-inducing activity. J Neurosci. 13:2118–2125. 1993. View Article : Google Scholar : PubMed/NCBI

49 

Chae KS, Martin-Caraballo M, Anderson M and Dryer SE: Akt activation is necessary for growth factor-induced trafficking of functional K (Ca) channels in developing parasympathetic neurons. J Neurophysiol. 93:1174–1182. 2005. View Article : Google Scholar : PubMed/NCBI

50 

Castillo C, Malavé C, Martínez JC, Núñez J, Hernández D, Pasquali F, Villegas GM and Villegas R: Neuregulin-1 isoform induces mitogenesis, KCa and Ca2+ currents in PC12 cells. A comparison with sciatic nerve conditioned medium. Brain Res. 1110:64–75. 2006. View Article : Google Scholar : PubMed/NCBI

51 

Janse MJ, Kleber AG, Capucci A, Coronel R and Wilms-Schopman F: Electrophysiological basis for arrhythmias caused by acute ischemia. Role of the subendocardium. J Mol Cell Cardiol. 18:339–355. 1986. View Article : Google Scholar : PubMed/NCBI

52 

Kléber AG, Janse MJ, Wilms-Schopmann FJ, Wilde AA and Coronel R: Changes in conduction velocity during acute ischemia in ventricular myocardium of the isolated porcine heart. Circulation. 73:189–198. 1986. View Article : Google Scholar : PubMed/NCBI

53 

Wang XH, Zhuo XZ, Ni YJ, Gong M, Wang TZ, Lu Q and Ma AQ: Improvement of cardiac function and reversal of gap junction remodeling by Neuregulin-1β in volume-overloaded rats with heart failure. J Geriatr Cardiol. 9:172–179. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Rao P, Liu Z, Duan H, Dang S, Li H, Zhong L, Wang X, Wang L and Wang X: Pretreatment with neuregulin‑1 improves cardiac electrophysiological properties in a rat model of myocardial infarction. Exp Ther Med 17: 3141-3149, 2019.
APA
Rao, P., Liu, Z., Duan, H., Dang, S., Li, H., Zhong, L. ... Wang, X. (2019). Pretreatment with neuregulin‑1 improves cardiac electrophysiological properties in a rat model of myocardial infarction. Experimental and Therapeutic Medicine, 17, 3141-3149. https://doi.org/10.3892/etm.2019.7306
MLA
Rao, P., Liu, Z., Duan, H., Dang, S., Li, H., Zhong, L., Wang, X., Wang, L., Wang, X."Pretreatment with neuregulin‑1 improves cardiac electrophysiological properties in a rat model of myocardial infarction". Experimental and Therapeutic Medicine 17.4 (2019): 3141-3149.
Chicago
Rao, P., Liu, Z., Duan, H., Dang, S., Li, H., Zhong, L., Wang, X., Wang, L., Wang, X."Pretreatment with neuregulin‑1 improves cardiac electrophysiological properties in a rat model of myocardial infarction". Experimental and Therapeutic Medicine 17, no. 4 (2019): 3141-3149. https://doi.org/10.3892/etm.2019.7306
Copy and paste a formatted citation
x
Spandidos Publications style
Rao P, Liu Z, Duan H, Dang S, Li H, Zhong L, Wang X, Wang L and Wang X: Pretreatment with neuregulin‑1 improves cardiac electrophysiological properties in a rat model of myocardial infarction. Exp Ther Med 17: 3141-3149, 2019.
APA
Rao, P., Liu, Z., Duan, H., Dang, S., Li, H., Zhong, L. ... Wang, X. (2019). Pretreatment with neuregulin‑1 improves cardiac electrophysiological properties in a rat model of myocardial infarction. Experimental and Therapeutic Medicine, 17, 3141-3149. https://doi.org/10.3892/etm.2019.7306
MLA
Rao, P., Liu, Z., Duan, H., Dang, S., Li, H., Zhong, L., Wang, X., Wang, L., Wang, X."Pretreatment with neuregulin‑1 improves cardiac electrophysiological properties in a rat model of myocardial infarction". Experimental and Therapeutic Medicine 17.4 (2019): 3141-3149.
Chicago
Rao, P., Liu, Z., Duan, H., Dang, S., Li, H., Zhong, L., Wang, X., Wang, L., Wang, X."Pretreatment with neuregulin‑1 improves cardiac electrophysiological properties in a rat model of myocardial infarction". Experimental and Therapeutic Medicine 17, no. 4 (2019): 3141-3149. https://doi.org/10.3892/etm.2019.7306
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team